A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis

NCT05951816 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Systemic Amyloidosis

Interventions

DRUG: 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.
DRUG: 99mTc-Pyrophosphate and 99mtc-p5+14 - an Amyloid Reactive Peptide Labeled With Technetium-99m.

Sponsor

University of Tennessee Graduate School of Medicine

Collaborators

[object Object]